Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation

Oncogene

Volumn 21, Issue 57, 2002, Pages 8852-8861

  Mukhopadhyay, Asok ^a   Banerjee, Sanjeev ^a   Stafford, Lewis Joe ^b   Xia, Chunzhi ^b   Liu, Mingyao ^b   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

CDK4; Curcumin; Cyclin D1; NF B; Rb; Retinoic acid

Indexed keywords

CURCUMIN; CYCLIN D1; CYCLIN D2; CYCLIN D3; LACTACYSTIN; RETINOBLASTOMA PROTEIN; RETINOIC ACID;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REPORTER GENE; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

ACETYLCYSTEINE; BASE SEQUENCE; CELL DIVISION; CURCUMIN; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA PRIMERS; DOWN-REGULATION; HUMANS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037069939     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206048     Document Type: Article

References (53)

1. Adelaide J, Monges G, Derderian C, Seitz JF and Birnbaum D. (1995). Br. J. Cancer., 71, 64-68.
2. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A and Pestell RG. (1995). J. Biol. Chem., 270, 23589-23597.
3. Anto RJ, Mukhopadhyay A, Denning K and Aggarwal BB. (2002). Carcinogenesis, 23, 143-150.
4. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB and Holt PR. (1996). Gastroenterology, 110, 669-674.
5. Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G. (1993). Genes Dev., 7, 812-821.
6. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M and Bartek J. (1994a). Intl. J. Cancer, 57, 353-361.
7. Bartkova J, Lukas J, Strauss M and Bartek J. (1994b). Intl. J. Cancer, 58, 568-573.
8. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B and Bartek J. (1995). Cancer Res., 55, 949-956.
9. Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi BVV and Khar A. (1999). FEBS Lett., 456, 311-314.
10. Caputi M, Groeger AM, Esposito V, Dean C, De Luca A, Pacilio C, Muller MR, Giordano GG, Baldi F, Wolner E and Giordano A. (1999). Am. J. Respir. Cell Mol. Biol., 20, 746-750.
11. Chen HW and Huang HC. (1998). Br. J. Pharmacol., 124, 1029-1040.
12. Chen H, Zhang ZS, Zhang YL and Zhou DY. (1999). Anticancer Res., 19, 3675-3680.
13. Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y and Beauchamp RD. (2001). Cancer Res., 61, 5389-5395.
14. Dickson C, Fantl V, Gillett C, Brookes S, Bartek J, Smith R, Fisher C, Barnes D and Peters G. (1995). Cancer Letts., 90, 43-50.
15. Diehl JA, Zindy F and Sherr CJ. (1997). Genes Dev., 11, 957-972.
16. Drobnjak M, Osman I, Scher HI, Fazzari M and Cordon-Cardo C. (2000). Clin. Cancer Res., 6, 1891-1895.
17. Duckett CS, Perkins ND, Leung K, Agranoff AB and Nabel GJ. (1995). J. Biol. Chem., 270, 18836-18840.
18. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J and Sukumar S. (2001). Cancer Res., 61, 2782-2787.
19. Fantl V, Creer A, Dillon C, Bresnick J, Jackson D, Edwards P, Rosewell I and Dickson C. (2000). Adv. Exp. Med. Biol., 480, 1-7.
20. Fantl V, Stamp G, Andrews A, Rosewell I and Dickson C. (1995). Genes Dev., 9, 2364-2372.
21. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G. (1994). Cancer Res., 54, 1812-1817.
22. Gumbiner LM, Gumerlock PH, Mack PC, Chi SG, deVere White RW, Mohler JL, Pretlow TG and Tricoli JV. (1999). Prostate, 38, 40-45.
23. Guttridge DC, Albanese C, Reuther JY, Pestell RG and Baldwin Jr AS. (1999). Mol. Cell. Biol., 19, 5785-5799.
24. Han SS, Chung ST, Robertson DA, Ranjan D and Bondada S. (1999). Clin. Immunol., 93, 152-161.
25. Harari D and Yarden Y. (2000). Oncogene, 19, 6102-6114.
26. Haridas V, Darnay BG, Natarajan K, Heller R and Aggarwal BB. (1998). J. Immunol., 160, 3152-3162.
27. Henry DO, Moskalenko SA, Kaur KJ, Fu M, Pestell RG, Camonis JH and White MA. (2000). Mol. Cell. Biol., 20, 8084-8092.
28. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C and Strauss M. (1999). Mol. Cell. Biol., 19, 2690-2698.
29. Jiang MC, Yang-Yen HF, Yen JJ and Lin JK et al. (1996). Nutr. Cancer, 26, 111-120.
30. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA and Sartor RB. (1999). J. Immunol., 163, 3474-3483.
31. Joyce D, Bouzahzah B, Fu M, Albanese C, d'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ and Pestell RG. (1999). J. Biol. Chem., 274, 25245-25249.
32. Kumar A, Dhawan S, Hardegen NJ and Aggarwal BB. (1998). Biochem. Pharmacol., 55, 775-783.
33. Kuo ML, Huang TS and Lin JK. (1996). Biochim. Biophys. Acta, 1317, 95-100.
34. Langenfeld J, Kiyokawa H, Sekula D, Boyle J and Dmitrovsky E. (1997). Proc. Natl. Acad. Sci. USA, 9, 12070-12074.
35. Lee RJ, Albanese C, Fu M, d'Amico M, Lin B, Watanabe G, Haines III GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ and Pestell RG. (2000). Mol. Cell. Biol., 20, 672-683.
36. Liu M and Simon MI. (1996). Nature, 382, 83-87.
37. Lukas J, Bartkova J, Welcker M, Petersen OW, Peters G, Strauss M and Bartek J. (1995). Oncogene, 10, 2125-2134.
38. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato JY. (1994). Mol. Cell. Biol., 14, 2066-2076.
39. Mehta K, Pantazis P, McQueen T and Aggarwal BB. (1997). Anticancer Drugs, 8, 470-481.
40. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K and Ikenaga M. (1994). Cancer Res., 54, 3107-3110.
41. Pervin S, Singh R and Chaudhuri G. (2001). Proc. Natl. Acad. Sci. USA, 98, 3583-3588.
42. Piwocka K, Zablocki K, Wieckowski MR and Sikora E. (1999). Exp. Cell. Res., 249, 299-307.
43. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S and Howells L. (1999). Oncogene, 18, 6013-6020.
44. Ramachandran C and You W. (1999). Breast Cancer Res. Treat., 54, 269-278.
45. Ranjan D, Johnston TD, Reddy KS, Wu G, Bondada S and Chen C. (1999). J. Surg. Res., 87, 1-5.
46. Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ, Cheffetz S and Herlyn M. (1999). Cancer Res., 59, 4876-4881.
47. Sherr CJ. (1995). Trends Biochem. Sci., 20, 187-190.
48. Sicinski P and Weinberg RA. (1997). J. Mamm. Gland Biol. Neoplasia, 2, 335-342.
49. Simon A, Allais DP, Duroux JL, Basly JP, Durand-Fontanier S and Delage C. (1998). Cancer Lett., 129, 111-116.
50. Singh S and Aggarwal BB. (1995). J. Biol. Chem., 270, 24995.
51. Vrana JA and Grant S. (2001). Blood, 97, 2105-2114.
52. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV. (1994). Nature, 369, 669-671.
53. Yu Q, Geng Y and Sicinski P. (2001). Nature, 411, 1017-1021.